Overview

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The present study is designed to confirm and extend the observation from previous studies that lixivaptan therapy corrects hyponatremia, in euvolemic subject, including subjects with SIADH.

Phase:

Phase 3

Details

Lead Sponsor:

CardioKine Inc.

Collaborators:

Biogen
Cardiokine Biopharma, LLC